{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T21:41:03Z","timestamp":1785361263164,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":51,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Project of the Nanjing Medical Science and Technique Development Foundation","award":["YKK21183"],"award-info":[{"award-number":["YKK21183"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48627-8","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T06:53:57Z","timestamp":1776149637000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["M2 type macrophages promote OSCC progress via conferring resistance to Erastin-induced ferroptosis"],"prefix":"10.1038","volume":"16","author":[{"given":"Chuanchao","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijie","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runzhi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"issue":"1","key":"48627_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"SiegelRL, Miller, D. & Jemal, A. Cancer statistics, 2020. CACancer J. Clin. 70 (1), 7\u201330 (2020).","journal-title":"CACancer J. Clin."},{"key":"48627_CR2","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.omtn.2020.09.001","volume":"22","author":"R Saikishore","year":"2020","unstructured":"Saikishore, R. et al. The circr RNA-miRNAAxis: a special RNA signature regulatory transcriptome as a potential biomarker for OSCC. Mol. Ther. Nucleic Acids. 22, 352\u2013361 (2020).","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"7","key":"48627_CR3","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1002\/lary.30351","volume":"133","author":"AT Bourdillon","year":"2023","unstructured":"Bourdillon, A. T., Shah, H. P., Cohen, O., Hajek, M. A. & Mehra, S. Novel machine learning model to predict interval of oral cancer recurrence for surveillance stratification. Laryngoscope 133 (7), 1652\u20131659 (2023).","journal-title":"Laryngoscope"},{"issue":"5","key":"48627_CR4","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.7150\/thno.82690","volume":"13","author":"W Luo","year":"2023","unstructured":"Luo, W. Nasopharyngeal carcinoma ecology theory: cancer as multidimensional spatiotemporal unity of ecology and evolution pathological ecosystem. Theranostics 13 (5), 1607\u20131631 (2023).","journal-title":"Theranostics"},{"key":"48627_CR5","doi-asserted-by":"publisher","first-page":"109821","DOI":"10.1016\/j.biopha.2020.109821","volume":"124","author":"S Tan","year":"2020","unstructured":"Tan, S., Li, D. & Zhu, X. Cancer immunotherapy: pros, cons and beyond. Biomed. Pharmacother. 124, 109821 (2020).","journal-title":"Biomed. Pharmacother."},{"issue":"13","key":"48627_CR6","doi-asserted-by":"publisher","first-page":"6995","DOI":"10.3390\/ijms22136995","volume":"22","author":"AJ Boutilier","year":"2021","unstructured":"Boutilier, A. J. & Elsawa, S. F. Macrophage polarization states in the tumor microenvironment. Int. J. Mol. Sci. 22 (13), 6995 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"48627_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.31083\/j.fbl2707203","volume":"27","author":"Z Zhou","year":"2022","unstructured":"Zhou, Z. et al. Targeting the macrophage-ferroptosis crosstalk: a novel insight into tumor immunotherapy. Front. Biosci. (Landmark Ed). 27 (7), 203 (2022).","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"48627_CR8","doi-asserted-by":"publisher","first-page":"583084","DOI":"10.3389\/fimmu.2020.583084","volume":"11","author":"Y Pan","year":"2020","unstructured":"Pan, Y., Yu, Y., Wang, X. & Zhang, T. Tumor-associated macrophages in tumor immunity. Front. Immunol. 11, 583084 (2020).","journal-title":"Front. Immunol."},{"key":"48627_CR9","doi-asserted-by":"publisher","first-page":"102371","DOI":"10.1016\/j.nano.2021.102371","volume":"34","author":"D Bhattacharya","year":"2021","unstructured":"Bhattacharya, D. et al. The prospects of nanotherapeutic approaches for targeting tumor-associated macrophages in oral cancer. Nanomedicine 34, 102371 (2021).","journal-title":"Nanomedicine"},{"issue":"7679","key":"48627_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer, M. J. et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature 551 (7679), 247\u2013250 (2017).","journal-title":"Nature"},{"issue":"2","key":"48627_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/cac2.12250","volume":"42","author":"L Zhao","year":"2022","unstructured":"Zhao, L. et al. Ferroptosis in cancer and cancer immunotherapy. Cancer Commun. (Lond). 42 (2), 88\u2013116 (2022).","journal-title":"Cancer Commun. (Lond)"},{"issue":"5","key":"48627_CR12","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen, X., Kang, R., Kroemer, G. & Tang, D. Broadening horizons: the role of ferroptosis in cancer. Nat. Rev. Clin. Oncol. 18 (5), 280\u2013296. https:\/\/doi.org\/10.1038\/s41571-020-00462-0 (2021). Epub 2021 Jan 29.","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7755","key":"48627_CR13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang, W. et al. CD8\u2009+\u2009T cells regulate tumour ferroptosis during cancer immunotherapy. Nature 569 (7755), 270\u2013274 (2019).","journal-title":"Nature"},{"issue":"1","key":"48627_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-020-01168-8","volume":"19","author":"H Zhang","year":"2020","unstructured":"Zhang, H. et al. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol. Cancer. 19 (1), 43 (2020).","journal-title":"Mol. Cancer"},{"key":"48627_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.canlet.2021.12.011","volume":"527","author":"M Li","year":"2022","unstructured":"Li, M., Jin, S., Zhang, Z., Ma, H. & Yang, X. Interleukin-6 facilitates tumor progression by inducing ferroptosis resistance in head and neck squamous cell carcinoma. Cancer Lett. 527, 28\u201340 (2022).","journal-title":"Cancer Lett."},{"issue":"1","key":"48627_CR16","doi-asserted-by":"publisher","first-page":"5279","DOI":"10.1080\/21655979.2021.1964158","volume":"12","author":"F Han","year":"2021","unstructured":"Han, F., Li, S., Yang, Y. & Bai, Z. Interleukin-6 promotes ferroptosis in bronchial epithelial cells by inducing reactive oxygen species-dependent lipid peroxidation and disrupting iron homeostasis. Bioengineered 12 (1), 5279\u20135288 (2021).","journal-title":"Bioengineered"},{"key":"48627_CR17","doi-asserted-by":"publisher","first-page":"727762","DOI":"10.3389\/fcell.2021.727762","volume":"9","author":"ZW Hu","year":"2021","unstructured":"Hu, Z. W. et al. Ferroptosis driver SOCS1 and suppressor FTH1 independently correlate with M1 and M2 macrophage infiltration in head and neck squamous cell carcinoma. Front. Cell. Dev. Biology. 9, 727762 (2021).","journal-title":"Front. Cell. Dev. Biology"},{"key":"48627_CR18","doi-asserted-by":"publisher","first-page":"817643","DOI":"10.3389\/fcell.2022.817643","volume":"10","author":"J Shi","year":"2022","unstructured":"Shi, J. et al. Identification of ferroptosis-related biomarkers for prognosis and immunotherapy in patients with glioma. Front. Cell. Dev. Biology. 10, 817643 (2022).","journal-title":"Front. Cell. Dev. Biology"},{"issue":"5","key":"48627_CR19","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144 (5), 646\u2013674 (2011).","journal-title":"Cell"},{"key":"48627_CR20","doi-asserted-by":"publisher","first-page":"611115","DOI":"10.3389\/fonc.2021.611115","volume":"11","author":"EM Kalogirou","year":"2021","unstructured":"Kalogirou, E. M., Tosios, K. I. & Christopoulos, P. F. The role of macrophages in oral squamous cell carcinoma. Front. Oncol. 11, 611115 (2021).","journal-title":"Front. Oncol."},{"issue":"1","key":"48627_CR21","doi-asserted-by":"publisher","first-page":"2063225","DOI":"10.1080\/2162402X.2022.2063225","volume":"11","author":"K Kos","year":"2022","unstructured":"Kos, K. et al. Tumor-associated macrophages promote intratumoral conversion of conventional CD4(+) T cells into regulatory T cells via PD-1 signalling. Oncoimmunology 11 (1), 2063225. https:\/\/doi.org\/10.1080\/2162402X.2022.2063225 (2022).","journal-title":"Oncoimmunology"},{"key":"48627_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-015-0281-z","author":"Y Hu","year":"2016","unstructured":"Hu, Y. et al. Tumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinoma. J. Exp. Clin. Cancer Res. https:\/\/doi.org\/10.1186\/s13046-015-0281-z (2016).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"48627_CR23","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s11596-019-2051-1","volume":"39","author":"JJ Li","year":"2019","unstructured":"Li, J. J. et al. Role of PFKFB3 and CD163 in oral squamous cell carcinoma angiogenesis. Curr. Med. Sci. 39 (3), 410\u2013414. https:\/\/doi.org\/10.1007\/s11596-019-2051-1 (2019).","journal-title":"Curr. Med. Sci."},{"issue":"1","key":"48627_CR24","doi-asserted-by":"publisher","first-page":"1944554","DOI":"10.1080\/2162402X.2021.1944554","volume":"10","author":"J Bouaoud","year":"2021","unstructured":"Bouaoud, J. et al. Early changes in the immune microenvironment of oral potentially malignant disorders reveal an unexpected association of M2 macrophages with oral cancer free survival. Oncoimmunology 10 (1), 1944554. https:\/\/doi.org\/10.1080\/2162402X.2021.1944554 (2021).","journal-title":"Oncoimmunology"},{"issue":"7","key":"48627_CR25","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.oraloncology.2015.04.004","volume":"51","author":"KC Chiu","year":"2015","unstructured":"Chiu, K. C. et al. Polarization of tumor-associated macrophages and Gas6\/Axl signaling in oral squamous cell carcinoma. Oral Oncol. 51 (7), 683\u2013689. https:\/\/doi.org\/10.1016\/j.oraloncology.2015.04.004 (2015).","journal-title":"Oral Oncol."},{"issue":"6","key":"48627_CR26","doi-asserted-by":"publisher","first-page":"e1397","DOI":"10.1002\/cti2.1397","volume":"11","author":"HS Rad","year":"2022","unstructured":"Rad, H. S. et al. Understanding the tumor microenvironment in head and neck squamous cell carcinoma. Clin. Transl Immunol. 11 (6), e1397 (2022).","journal-title":"Clin. Transl Immunol."},{"key":"48627_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5524231","author":"Y Ai","year":"2021","unstructured":"Ai, Y. et al. lncRNA DCST1-AS1 facilitates oral squamous cell carcinoma by promoting M2 macrophage polarization through activating NF-\u03baB signaling. J. Immunol. Res. https:\/\/doi.org\/10.1155\/2021\/5524231 (2021).","journal-title":"J. Immunol. Res."},{"issue":"1","key":"48627_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s40487-022-00214-3","volume":"11","author":"E Allison","year":"2023","unstructured":"Allison, E., Edirimanne, S., Matthews, J. & Fuller, S. J. Breast cancer survival outcomes and tumor-associated macrophage markers: a systematic review and meta-analysis. Oncol. Ther. 11 (1), 27\u201348 (2023).","journal-title":"Oncol. Ther."},{"key":"48627_CR29","doi-asserted-by":"publisher","first-page":"888713","DOI":"10.3389\/fimmu.2022.888713","volume":"13","author":"J Gao","year":"2022","unstructured":"Gao, J., Liang, Y. & Wang, L. Shaping polarization of tumor-associated macrophages in cancer immunotherapy. Front. Immunol. 13, 888713 (2022).","journal-title":"Front. Immunol."},{"key":"48627_CR30","doi-asserted-by":"publisher","first-page":"1295684","DOI":"10.3389\/fimmu.2023.1295684","volume":"14","author":"S Shao","year":"2023","unstructured":"Shao, S., Miao, H. & Ma, W. Unraveling the enigma of tumor-associated macrophages: challenges, innovations, and the path to therapeutic breakthroughs. Front. Immunol. 14, 1295684 (2023).","journal-title":"Front. Immunol."},{"issue":"1","key":"48627_CR31","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1038\/s41467-021-23164-2","volume":"12","author":"YC Wang","year":"2021","unstructured":"Wang, Y. C. et al. Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy. Nat. Commun. 12 (1), 3530. https:\/\/doi.org\/10.1038\/s41467-021-23164-2 (2021).","journal-title":"Nat. Commun."},{"issue":"11","key":"48627_CR32","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1158\/2326-6066.CIR-23-0133","volume":"11","author":"YM Lee","year":"2023","unstructured":"Lee, Y. M. et al. Genomic and transcriptomic landscape of an oral squamous cell carcinoma mouse model for immunotherapy. Cancer Immunol. Res. 11 (11), 1553\u20131567 (2023).","journal-title":"Cancer Immunol. Res."},{"key":"48627_CR33","doi-asserted-by":"publisher","first-page":"103375","DOI":"10.1016\/j.ebiom.2021.103375","volume":"67","author":"M Zhou","year":"2021","unstructured":"Zhou, M. et al. Tumor-associated macrophages in cholangiocarcinoma: complex interplay and potential therapeutic target. EBioMedicine 67, 103375 (2021).","journal-title":"EBioMedicine"},{"key":"48627_CR34","doi-asserted-by":"publisher","first-page":"1034842","DOI":"10.3389\/fonc.2022.1034842","volume":"12","author":"X Shen","year":"2022","unstructured":"Shen, X. et al. TAM-targeted reeducation for enhanced cancer immunotherapy: mechanism and recent progress. Front. Oncol. 12, 1034842 (2022).","journal-title":"Front. Oncol."},{"key":"48627_CR35","doi-asserted-by":"publisher","first-page":"1026898","DOI":"10.3389\/fimmu.2022.1026898","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang, J. et al. Tumor-associated macrophages in tumor progression and the role of traditional Chinese medicine in regulating TAMs to enhance antitumor effects. Front. Immunol. 13, 1026898 (2022).","journal-title":"Front. Immunol."},{"key":"48627_CR36","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang, J. et al. Guidelines and definitions for research on epithelial-mesenchymal transition. Nat. Rev. Mol. Cell. Biol. 21, 341\u2013352 (2020).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"48627_CR37","doi-asserted-by":"publisher","first-page":"1344290","DOI":"10.3389\/fonc.2024.1344290","volume":"14","author":"H Zhang","year":"2024","unstructured":"Zhang, H. et al. Ferroptosis and EMT resistance in cancer: a comprehensive review of the interplay. Front. Oncol. 14, 1344290 (2024).","journal-title":"Front. Oncol."},{"issue":"6","key":"48627_CR38","first-page":"463","volume":"47","author":"WR Luo","year":"2025","unstructured":"Luo, W. R. Rethinking cancer. Zhonghua Zhong Liu Za Zhi. 47 (6), 463\u2013467 (2025).","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"48627_CR39","doi-asserted-by":"publisher","DOI":"10.7551\/mitpress\/12111.001.0001","volume-title":"Rethinking Cancer: A New Paradigm for the Postgenomics Era","author":"B Strauss","year":"2021","unstructured":"Strauss, B. et al. Rethinking Cancer: A New Paradigm for the Postgenomics Era (MIT Press, 2021)."},{"issue":"3","key":"48627_CR40","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","volume":"15","author":"WS Yang","year":"2008","unstructured":"Yang, W. S. & Stockwell, B. R. Synthetic lethal screening identifies compounds activating iron\u2014dependent, nonapoptotic cell death in oncogenic\u2014RAS\u2014harboring cancer cells. Chem. Biol. 15 (3), 234\u2013245 (2008).","journal-title":"Chem. Biol."},{"key":"48627_CR41","doi-asserted-by":"publisher","first-page":"103847","DOI":"10.1016\/j.ebiom.2022.103847","volume":"76","author":"Y Miao","year":"2022","unstructured":"Miao, Y. et al. Contribution of ferroptosis and GPX4\u2019s dual functions to osteoarthritis progression. EBioMedicine 76, 103847 (2022).","journal-title":"EBioMedicine"},{"issue":"38","key":"48627_CR42","doi-asserted-by":"publisher","first-page":"31703","DOI":"10.1074\/jbc.M112.377804","volume":"287","author":"A Sakurai","year":"2012","unstructured":"Sakurai, A., Matsuda, M. & Kiyokawa, E. Activated Ras protein accelerates cell cycle progression to perturb Madin-Darby canine kidney cystogenesis. J. Biol. Chem. 287 (38), 31703\u201331711 (2012).","journal-title":"J. Biol. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48627-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48627-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48627-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:56:41Z","timestamp":1780531001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48627-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48627"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48627-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7157629\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17290"}}